RUNX1 and acute lymphoblastic leukemia: Prior studies reported molecular abnormalities associated with relapse in childhood ALL, but they did not identify a molecular signature that is present at diagnosis and is prognostic of early relapse in ETV6::RUNX1‐positive B‐cell ALL [4, 10–22].